PHIO PHARMACEUTICALS CORP. Research and Development Expense
PHIO PHARMACEUTICALS CORP. (PHIO) reported Research and Development Expense of $3.08 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-06
- PHIO PHARMACEUTICALS CORP. research and development expense for the quarter ending 2026-06-30 was $3.08M, a 186.96% increase year-over-year.
- PHIO PHARMACEUTICALS CORP. research and development expense for the quarter ending 2026-03-31 was $2.79M, a 215.24% increase year-over-year.
- PHIO PHARMACEUTICALS CORP. research and development expense for the quarter ending 2025-12-31 was $1.48M, a 49.95% increase year-over-year.
- PHIO PHARMACEUTICALS CORP. research and development expense for the quarter ending 2025-09-30 was $1.18M, a 83.39% increase year-over-year.
- PHIO PHARMACEUTICALS CORP. research and development expense for fiscal 2025 was $4.62M, a 26.76% increase from fiscal 2024.
- PHIO PHARMACEUTICALS CORP. research and development expense for fiscal 2024 was $3.64M, a 42.47% decline from fiscal 2023.
- PHIO PHARMACEUTICALS CORP. research and development expense for fiscal 2023 was $6.33M, a 9.70% decline from fiscal 2022.
- PHIO PHARMACEUTICALS CORP. research and development expense for fiscal 2022 was $7.01M, a 21.09% decline from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed | Research and Development Expense 114 month | Research and Development Expense 117 month | Research and Development Expense 120 month |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.08M 10-Q · filed 2026-08-06 | $5.87M 10-Q · filed 2026-08-06 | $7.35M derived: sum of 3 quarters · filed 2026-08-06 | $8.53M derived: sum of 4 quarters · filed 2026-08-06 | |||||||
| 2026-03-31 | $2.79M 10-Q · filed 2026-05-07 | $4.27M derived: sum of 2 quarters · filed 2026-05-07 | $5.45M derived: sum of 3 quarters · filed 2026-05-07 | $6.53M derived: sum of 4 quarters · filed 2026-08-06 | |||||||
| 2025-12-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $2.66M derived: sum of 2 quarters · filed 2026-03-05 | $3.73M derived: sum of 3 quarters · filed 2026-08-06 | $4.62M 10-K · filed 2026-03-05 | |||||||
| 2025-09-30 | $1.18M 10-Q · filed 2025-11-13 | $2.25M derived: sum of 2 quarters · filed 2026-08-06 | $3.14M 10-Q · filed 2025-11-13 | $4.13M derived: sum of 4 quarters · filed 2026-08-06 | |||||||
| 2025-06-30 | $1.07M 10-Q · filed 2026-08-06 | $1.96M 10-Q · filed 2026-08-06 | $2.94M derived: sum of 3 quarters · filed 2026-08-06 | $3.59M derived: sum of 4 quarters · filed 2026-08-06 | |||||||
| 2025-03-31 | $886.00K 10-Q · filed 2026-05-07 | $1.87M derived: sum of 2 quarters · filed 2026-05-07 | $2.52M derived: sum of 3 quarters · filed 2026-05-07 | $3.38M derived: sum of 4 quarters · filed 2026-05-07 | |||||||
| 2024-12-31 | $985.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $1.63M derived: sum of 2 quarters · filed 2026-03-05 | $2.50M derived: sum of 3 quarters · filed 2026-03-05 | $3.64M 10-K · filed 2026-03-05 | |||||||
| 2024-09-30 | $644.00K 10-Q · filed 2025-11-13 | $1.51M derived: sum of 2 quarters · filed 2025-11-13 | $2.66M 10-Q · filed 2025-11-13 | $3.67M derived: sum of 4 quarters · filed 2025-11-13 | |||||||
| 2024-06-30 | $866.00K 10-Q · filed 2025-08-14 | $2.01M 10-Q · filed 2025-08-14 | $3.02M derived: sum of 3 quarters · filed 2025-08-14 | $4.83M derived: sum of 4 quarters · filed 2025-08-14 | |||||||
| 2024-03-31 | $1.15M 10-Q · filed 2025-05-15 | $2.15M derived: sum of 2 quarters · filed 2025-05-15 | $3.96M derived: sum of 3 quarters · filed 2025-05-15 | $5.35M derived: sum of 4 quarters · filed 2025-05-15 | |||||||
| 2023-12-31 | $1.01M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $2.81M derived: sum of 2 quarters · filed 2025-03-31 | $4.20M derived: sum of 3 quarters · filed 2025-03-31 | $6.33M 10-K · filed 2025-03-31 | |||||||
| 2023-09-30 | $1.81M 10-Q · filed 2024-11-14 | $3.19M derived: sum of 2 quarters · filed 2024-11-14 | $5.33M 10-Q · filed 2024-11-14 | $6.94M derived: sum of 4 quarters · filed 2024-11-14 | |||||||
| 2023-06-30 | $1.38M 10-Q · filed 2024-08-14 | $3.52M 10-Q · filed 2024-08-14 | $5.13M derived: sum of 3 quarters · filed 2024-08-14 | $7.64M derived: sum of 4 quarters · filed 2024-08-14 | |||||||
| 2023-03-31 | $2.13M 10-Q · filed 2024-05-09 | $3.75M derived: sum of 2 quarters · filed 2024-05-09 | $6.26M derived: sum of 3 quarters · filed 2024-05-09 | $7.56M derived: sum of 4 quarters · filed 2024-05-09 | |||||||
| 2022-12-31 | $1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $4.12M derived: sum of 2 quarters · filed 2024-04-01 | $5.43M derived: sum of 3 quarters · filed 2024-04-01 | $7.01M 10-K · filed 2024-04-01 | |||||||
| 2022-09-30 | $2.51M 10-Q · filed 2023-11-09 | $3.81M derived: sum of 2 quarters · filed 2023-11-09 | $5.40M 10-Q · filed 2023-11-09 | $7.62M derived: sum of 4 quarters · filed 2023-11-09 | |||||||
| 2022-06-30 | $1.30M 10-Q · filed 2023-08-10 | $2.89M 10-Q · filed 2023-08-10 | $5.12M derived: sum of 3 quarters · filed 2023-08-10 | $7.79M derived: sum of 4 quarters · filed 2023-08-10 | |||||||
| 2022-03-31 | $1.59M 10-Q · filed 2023-05-11 | $3.81M derived: sum of 2 quarters · filed 2023-05-11 | $6.48M derived: sum of 3 quarters · filed 2023-05-11 | $8.04M derived: sum of 4 quarters · filed 2023-05-11 | |||||||
| 2021-12-31 | $2.23M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $4.90M derived: sum of 2 quarters · filed 2023-03-22 | $6.46M derived: sum of 3 quarters · filed 2023-03-22 | $8.89M 10-K · filed 2023-03-22 | |||||||
| 2021-09-30 | $2.67M 10-Q · filed 2022-11-10 | $2.81M 10-Q · filed 2021-11-10 | $4.23M derived: sum of 2 quarters · filed 2022-11-10 | $6.66M 10-Q · filed 2022-11-10 | $7.09M 10-Q · filed 2021-11-10 | $7.12M derived: sum of 4 quarters · filed 2022-11-10 | |||||
| 2021-06-30 | $1.56M 10-Q · filed 2022-08-11 | $1.66M 10-Q · filed 2021-08-12 | $3.99M 10-Q · filed 2022-08-11 | $4.28M 10-Q · filed 2021-08-12 | $4.45M derived: sum of 3 quarters · filed 2022-08-11 | $5.71M derived: sum of 4 quarters · filed 2022-08-11 | |||||
| 2021-03-31 | $2.43M 10-Q · filed 2022-05-12 | $2.62M 10-Q · filed 2021-05-13 | $2.89M derived: sum of 2 quarters · filed 2022-05-12 | $4.15M derived: sum of 3 quarters · filed 2022-05-12 | $4.93M derived: sum of 4 quarters · filed 2022-05-12 | ||||||
| 2020-12-31 | $463.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $1.72M derived: sum of 2 quarters · filed 2022-03-22 | $2.50M derived: sum of 3 quarters · filed 2022-03-22 | $3.72M 10-K · filed 2022-03-22 | $4.43M 10-K · filed 2021-03-25 | ||||||
| 2020-09-30 | $1.26M 10-Q · filed 2021-11-10 | $2.04M derived: sum of 2 quarters · filed 2021-11-10 | $3.25M 10-Q · filed 2021-11-10 | $4.28M derived: sum of 4 quarters · filed 2021-11-10 | |||||||
| 2020-06-30 | $779.00K 10-Q · filed 2021-08-12 | $2.00M 10-Q · filed 2021-08-12 | $3.02M derived: sum of 3 quarters · filed 2021-08-12 | $4.06M derived: sum of 4 quarters · filed 2021-08-12 | |||||||
| 2020-03-31 | $1.22M 10-Q · filed 2021-05-13 | $2.24M derived: sum of 2 quarters · filed 2021-05-13 | $3.28M derived: sum of 3 quarters · filed 2021-05-13 | $4.43M derived: sum of 4 quarters · filed 2021-05-13 | |||||||
| 2019-12-31 | $1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $2.06M derived: sum of 2 quarters · filed 2021-03-25 | $3.21M derived: sum of 3 quarters · filed 2021-03-25 | $4.30M 10-K · filed 2021-03-25 | |||||||
| 2019-09-30 | $1.04M 10-Q · filed 2020-11-10 | $2.19M derived: sum of 2 quarters · filed 2020-11-10 | $3.28M 10-Q · filed 2020-11-10 | $4.22M derived: sum of 4 quarters · filed 2020-11-10 | |||||||
| 2019-06-30 | $1.15M 10-Q · filed 2020-08-12 | $2.23M 10-Q · filed 2020-08-12 | $3.18M derived: sum of 3 quarters · filed 2020-08-12 | $4.02M derived: sum of 4 quarters · filed 2020-08-12 | |||||||
| 2019-03-31 | $1.09M 10-Q · filed 2020-05-12 | $2.03M derived: sum of 2 quarters · filed 2020-05-12 | $2.87M derived: sum of 3 quarters · filed 2020-05-12 | $4.05M derived: sum of 4 quarters · filed 2020-05-12 | |||||||
| 2018-12-31 | $944.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $1.78M derived: sum of 2 quarters · filed 2020-03-26 | $2.96M derived: sum of 3 quarters · filed 2020-03-26 | $4.33M 10-K · filed 2020-03-26 | |||||||
| 2018-09-30 | $838.00K 10-Q · filed 2019-11-12 | $2.02M derived: sum of 2 quarters · filed 2019-11-12 | $3.38M 10-Q · filed 2019-11-12 | $4.59M derived: sum of 4 quarters · filed 2019-11-12 | |||||||
| 2018-06-30 | $1.18M 10-Q · filed 2019-08-12 | $2.54M 10-Q · filed 2019-08-12 | $3.75M derived: sum of 3 quarters · filed 2019-08-12 | $5.24M derived: sum of 4 quarters · filed 2019-08-12 | |||||||
| 2018-03-31 | $1.36M 10-Q · filed 2019-05-14 | $2.56M derived: sum of 2 quarters · filed 2019-05-14 | $4.05M derived: sum of 3 quarters · filed 2019-05-14 | $5.38M derived: sum of 4 quarters · filed 2019-05-14 | |||||||
| 2017-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-27 | $2.69M derived: sum of 2 quarters · filed 2019-03-27 | $4.02M derived: sum of 3 quarters · filed 2019-03-27 | $5.37M 10-K · filed 2019-03-27 | |||||||
| 2017-09-30 | $1.49M 10-Q · filed 2018-11-14 | $2.82M derived: sum of 2 quarters · filed 2018-11-14 | $4.17M 10-Q · filed 2018-11-14 | $5.47M derived: sum of 4 quarters · filed 2018-11-14 | |||||||
| 2017-06-30 | $1.33M 10-Q · filed 2018-08-14 | $2.68M 10-Q · filed 2018-08-14 | $3.98M derived: sum of 3 quarters · filed 2018-08-14 | $5.45M derived: sum of 4 quarters · filed 2018-08-14 | |||||||
| 2017-03-31 | $1.35M 10-Q · filed 2018-05-10 | $2.65M derived: sum of 2 quarters · filed 2018-05-10 | $4.12M derived: sum of 3 quarters · filed 2018-05-10 | $5.46M derived: sum of 4 quarters · filed 2018-05-10 | |||||||
| 2016-12-31 | $1.31M derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-26 | $2.77M derived: sum of 2 quarters · filed 2018-03-26 | $4.11M derived: sum of 3 quarters · filed 2018-03-26 | $5.42M 10-K · filed 2018-03-26 | |||||||
| 2016-09-30 | $1.46M 10-Q · filed 2016-11-10 | $2.80M derived: sum of 2 quarters · filed 2018-03-26 | $4.11M 10-Q/A · filed 2018-03-26 | $5.83M derived: sum of 4 quarters · filed 2018-03-26 | |||||||
| 2016-06-30 | $1.34M 10-Q/A · filed 2018-03-26 | $2.64M 10-Q/A · filed 2018-03-26 | $4.37M derived: sum of 3 quarters · filed 2018-03-26 | $6.10M derived: sum of 4 quarters · filed 2018-03-26 | |||||||
| 2016-03-31 | $1.30M 10-Q/A · filed 2018-03-26 | $3.03M derived: sum of 2 quarters · filed 2018-03-26 | $4.76M derived: sum of 3 quarters · filed 2018-03-26 | $6.12M derived: sum of 4 quarters · filed 2018-03-26 | |||||||
| 2015-12-31 | $1.72M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | $3.46M derived: sum of 2 quarters · filed 2017-03-30 | $4.82M derived: sum of 3 quarters · filed 2017-03-30 | $6.92M 10-K · filed 2017-03-30 | |||||||
| 2015-09-30 | $1.73M 10-Q · filed 2016-11-10 | $3.10M derived: sum of 2 quarters · filed 2016-11-10 | $5.20M 10-Q · filed 2016-11-10 | $6.76M derived: sum of 4 quarters · filed 2016-11-10 | |||||||
| 2015-06-30 | $1.36M 10-Q · filed 2016-08-11 | $3.47M 10-Q · filed 2016-08-11 | $5.03M derived: sum of 3 quarters · filed 2016-08-11 | $6.49M derived: sum of 4 quarters · filed 2016-08-11 | |||||||
| 2015-03-31 | $2.11M 10-Q · filed 2016-05-12 | $3.67M derived: sum of 2 quarters · filed 2016-05-12 | $5.13M derived: sum of 3 quarters · filed 2016-05-12 | $6.31M derived: sum of 4 quarters · filed 2016-05-12 | |||||||
| 2014-12-31 | $1.56M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $3.02M derived: sum of 2 quarters · filed 2016-03-30 | $4.20M derived: sum of 3 quarters · filed 2016-03-30 | $5.68M 10-K · filed 2016-03-30 | |||||||
| 2014-09-30 | $1.46M 10-Q · filed 2015-11-12 | $2.64M derived: sum of 2 quarters · filed 2015-11-12 | $4.12M 10-Q · filed 2015-11-12 | $5.56M derived: sum of 4 quarters · filed 2015-11-12 | |||||||
| 2014-06-30 | $1.18M 10-Q · filed 2015-08-12 | $2.66M 10-Q · filed 2015-08-12 | $4.10M derived: sum of 3 quarters · filed 2015-08-12 | $5.33M derived: sum of 4 quarters · filed 2015-08-12 | |||||||
| 2014-03-31 | $1.48M 10-Q · filed 2015-05-13 | $2.91M derived: sum of 2 quarters · filed 2015-05-13 | $4.14M derived: sum of 3 quarters · filed 2015-05-13 | $5.36M derived: sum of 4 quarters · filed 2015-05-13 | |||||||
| 2013-12-31 | $1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | $2.67M derived: sum of 2 quarters · filed 2015-03-30 | $3.88M derived: sum of 3 quarters · filed 2015-03-30 | $17.65M 10-K · filed 2015-03-30 | |||||||
| 2013-09-30 | $1.23M 10-Q · filed 2014-11-13 | $2.44M derived: sum of 2 quarters · filed 2014-11-13 | $16.21M 10-Q · filed 2014-11-13 | $17.35M derived: sum of 4 quarters · filed 2014-11-13 | |||||||
| 2013-06-30 | $1.21M 10-Q · filed 2014-08-14 | $14.98M 10-Q · filed 2014-08-14 | $16.12M derived: sum of 3 quarters · filed 2014-08-14 | $17.34M derived: sum of 4 quarters · filed 2014-08-14 | |||||||
| 2013-03-31 | $13.77M 10-Q · filed 2014-05-14 | $14.91M derived: sum of 2 quarters · filed 2014-05-14 | $16.12M derived: sum of 3 quarters · filed 2014-05-14 | $23.07M derived: sum of 4 quarters · filed 2014-05-14 | |||||||
| 2012-12-31 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $2.35M derived: sum of 2 quarters · filed 2014-03-28 | $9.30M derived: sum of 3 quarters · filed 2014-03-28 | $10.45M 10-K · filed 2014-03-28 | $56.18M 10-K · filed 2013-03-29 | ||||||
| 2012-09-30 | $1.21M 10-Q · filed 2013-11-14 | $8.16M derived: sum of 2 quarters · filed 2013-11-14 | $9.31M 10-Q · filed 2013-11-14 | $10.87M derived: sum of 4 quarters · filed 2013-11-14 | $55.05M 10-Q · filed 2012-11-13 | ||||||
| 2012-06-30 | $6.95M 10-Q · filed 2013-08-14 | $8.10M 10-Q · filed 2013-08-14 | $9.65M derived: sum of 3 quarters · filed 2013-08-14 | $10.78M derived: sum of 4 quarters · filed 2013-08-14 | $53.83M 10-Q · filed 2012-08-14 | ||||||
| 2012-03-31 | $1.15M 10-Q · filed 2013-05-15 | $2.70M derived: sum of 2 quarters · filed 2013-05-15 | $3.83M derived: sum of 3 quarters · filed 2013-05-15 | $5.62M derived: sum of 4 quarters · filed 2013-05-15 | |||||||
| 2011-12-31 | $1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-29 | $2.68M derived: sum of 2 quarters · filed 2013-03-29 | $4.47M derived: sum of 3 quarters · filed 2013-03-29 | $6.62M 10-K · filed 2013-03-29 | |||||||
| 2011-09-30 | $1.13M 10-Q · filed 2012-11-13 | $2.92M derived: sum of 2 quarters · filed 2012-11-13 | $5.07M 10-Q · filed 2012-11-13 | ||||||||
| 2011-06-30 | $1.79M 10-Q · filed 2012-08-14 | $3.95M 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |